I’m writing to you today as I fly home from Baltimore. My assistant, Dr. Jemma Sinclaire and I traveled there to officially begin a clinical trial that has been in the works for a couple of years now. I hope you enjoy the story of how this project came to be.
Years ago I met Dr. Amando Sardi. He’s an extraordinary gastroenterologist and oncological surgeon at Mercy Hospital in Baltimore, Maryland. Dr. Sardi and his team have perfected a surgical technique that has saved countless lives. When cancer is found in the gastrointestinal tract, many times a part of the intestine needs to be removed, along with other organs, like the gall bladder, spleen, and/or parts of the liver or stomach that may also be cancerous. Removal of parts of the intestine is called “bowel resection”.
Historically, after a surgery of this type, a person would then have to undergo whole body chemotherapy, a difficult and extremely taxing process to endure. It was not uncommon for the cancer to be technically gone, however the patient may have passed away from complications of the treatment.
Dr. Sardi’s unique treatment “perfuses the peritoneum” with chemotherapy. That means that after he removes the obvious cancerous growths and parts of the intestines that are involved, he fills the intestinal cavity with the cancer killing drug instead of allowing it to travel the entire body. In this way, the medicine is focused in the exact area where any remaining cancer cells may be, sparing the rest of the body from the debilitating side effects of chemo.
The total procedure is called Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Dr. Sardi has an amazing survival rate when he performs this protocol. However, after the initial healing phase, the quality of life the patients experience is often “in the toilet”. Sadly, chronic diarrhea is often unrelenting.
The term “Short Bowel Syndrome (SBS)” is used to describe those symptoms that may arise after bowel resection, diarrhea being one of the most persistent.
Initially, after a dramatic procedure of this type, there is a period of time during which a person’s body is stabilizing and adjusting, attempting to compensate for functional loss. It constantly amazes me how the human body is able to recover from that level of trauma.
Then the next phase of healing begins. Dr. Sardi’s vision, to be explored during the clinical trial, is to introduce appropriate nutritional support, through diet and supplementation along with targeted medication that will help a person to experience the highest quality of life possible. Surviving cancer surgery is one thing. Living life after cancer with a compromised intestinal tract is quite another.
This clinical trial was birthed in a conversation Dr. Sardi and I had about what might be possible for these people who had already endured so very much.
Through the Renew HOPE Foundation, Dr. Leonard Smith, Jemma and I along with Dr. Sardi’s team have designed a one-year research project that includes 10 patients who are all at least 2 years post surgery. Their cancer markers are within normal ranges. They are grateful to be alive.
We are teaching them about the HOPE Formula (High fiber, Omega-3s, Probiotics and digestive Enzymes) which I believe are the foundation of digestive health – for everyone.
Additionally we’re using aspects of the Skinny Gut Diet and are helping these people to rebalance the bacteria in their remaining bowel. It always comes back to supporting the good bacteria when you’re goal is improving digestive wellness and supporting the immune system.
I hope that soon we will be able to relate to you that the quality of life these people experience will be much improved.
I felt truly honored to meet with our first 5 patients along with Dr. Sardi and his excellent team, and I look forward to our next year together. I promise to keep you updated.